WAAG
TRIL

Wealth Alliance Advisory Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Wealth Alliance Advisory Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,800
Closed -$126K – 146
2018
Q3 		$126K Buy
+21,800
New +$126K 0.06% 137